Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway-Reference-Cited by-同舟云学术

Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway

Published:2015-10-19 Issue:39 Volume:6 Page:41794-41808
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Qin Ge¹,Xu Fei¹,Qin Tao¹,Zheng Qiufan¹,Shi Dingbo¹,Xia Wen¹,Tian Yun¹,Tang Yanlai²,Wang Jingshu¹,Xiao Xiangshen¹,Deng Wuguo¹,Wang Shusen¹

Affiliation:

1. Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China

2. Department of Pediatrics, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis;PLOS ONE;2024-07-11

2. Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy;Seminars in Cancer Biology;2024-05

3. Metformin: A Dual-Role Player in Cancer Treatment and Prevention;International Journal of Molecular Sciences;2024-04-06

4. Tetrastigma hemsleyanum (Sanyeqing) root extracts evoke S phase arrest while inhibiting the migration and invasion of human pancreatic cancer PANC-1 cells;BMC Complementary Medicine and Therapies;2024-03-27

5. CDK4/6 inhibitors in lung cancer: current practice and future directions;European Respiratory Review;2024-01-31